Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
October 27, 2023Peter Maybarduk on Paxlovid, Maya Schenwar on Grassroots Journalism27 minutesPlayPaxlovid's "transition" to the commercial market entails hiking the cost of the treatment to 100 times the cost of production....moreShareView all episodesBy Fairness & Accuracy In ReportingOctober 27, 2023Peter Maybarduk on Paxlovid, Maya Schenwar on Grassroots Journalism27 minutesPlayPaxlovid's "transition" to the commercial market entails hiking the cost of the treatment to 100 times the cost of production....more
Paxlovid's "transition" to the commercial market entails hiking the cost of the treatment to 100 times the cost of production.
October 27, 2023Peter Maybarduk on Paxlovid, Maya Schenwar on Grassroots Journalism27 minutesPlayPaxlovid's "transition" to the commercial market entails hiking the cost of the treatment to 100 times the cost of production....more
Paxlovid's "transition" to the commercial market entails hiking the cost of the treatment to 100 times the cost of production.